Cargando…

Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity

Fungal diseases have been emerging as an important public health problem worldwide with the increase in host predisposition factors due to immunological dysregulations, immunosuppressive and/or anticancer therapy. Antifungal therapy for systemic mycosis is limited, most of times expensive and causes...

Descripción completa

Detalles Bibliográficos
Autores principales: Souza, Ana C. O., Amaral, Andre C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340099/
https://www.ncbi.nlm.nih.gov/pubmed/28326065
http://dx.doi.org/10.3389/fmicb.2017.00336